Evolus (EOLS) Stock Highlights

10.89 | +0.18%

2024-12-21 04:45:55

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The companys first commercial product is Jeuveau, a proprietary of 900 kilodalton or kDa, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. The company generates product revenue from the sale of Jeuveau in the US.

Statistics

Range Today

10.73 11.16

Volume Today 979.9K

Range 1 Year

9.65 17.82

Volume 1 Year 147.33M

Range 3 Year

5.06 17.82

Volume 3 Year 415M

Range 10 Year

2.85 39.5

Volume 10 Year 1.08B

Highlights

Market Capitalization 866.24M (small)

Floating Shares 49.62M

Current Price 10.89

Price To Earnings -16.41

Price To Revenue 3.62

Price To Book 147.1

Earnings Per Share -0.87

Payout Ratio 0%

Performance

Latest +0.18%

1 Month -11.89%

3 Months -34.28%

6 Months +2.93%

1 Year +7.4%

3 Years +79.11%

5 Years -12.88%

10 Years -3.2%

Benchmarks

Market Capitalization

23 / 54

Gross Profits

24 / 39

Total Revenue

29 / 50

Total Rank

36 / 54

Free Cashflow

42 / 54

Performance 5 years

17 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.